Skip to content

Trial to assess the safety and antitumor activity of GEN1057 on malignant solid tumors

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513563-75-00
Acronym
GCT1057-01
Enrollment
18
Registered
2024-09-11
Start date
2025-03-20
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metastatic or advanced malignant solid tumors

Interventions

None listed

Sponsors

Genmab A/S
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026